Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial

• UTSUNOMIYA Masako

• DOBASHI Hiroaki

• ODANI Toshio

• SAITO Kazuyoshi

• YOKOGAWA Naoto

• NAGASAKA Kenji

• TAKENAKA Kenchi

• SOEJIMA Makoto

• SUGIHARA Takahiko

• HAGIYAMA Hiroyuki

• HIRATA Shinya

• MATSU Kazuo

• NONOMURA Yoshinori

• KONDO Masahiro

• SUZUKI Fumihito

• TOMITA Makoto

• KIHARA Mari

• YOKOYAMA Waka

• HIRANO Fumio

• YAMAZAKI Hayato

• SAKAI Ryoko

• NANKI Toshihiro

• KOIKE Ryuji

• KOHSAKA Hitoshi

• MIYASAKA Nobuyuki

• HARIGAI Masayoshi

収録刊行物

• Arthritis Research & Therapy

  Arthritis Research & Therapy 19 7-, 2017-01-18

  BioMed Central

キーワード

• Drug discontinuation rate
• Efficacy
• Pneumocystis pneumonia
• Prophylaxis
• Randomized controlled trial
• Rheumatic disease
• Safety
• Sulfamethoxazole-trimethoprim

詳細情報

• CRID: 1390009224750567296
• NII論文ID: 120006239235
• DOI: 10.20780/00031626
• DOI: 10.1186/s13075-016-1206-8
• HANDLE: 10470/00031626
• ISSN: 14786362
• PubMed: 28100282
• Web Site: https://twinkle.repo.nii.ac.jp/records/23932
• Web Site: http://link.springer.com/content/pdf/10.1186/s13075-016-1206-8.pdf
• 本文言語コード: en
• データソース種別:
  • JaLC
  • IRDB
  • Crossref
  • PubMed
  • CiNii Articles